Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0003 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |